CXCL12 rs1801157 polymorphism is associated with risk and poor prognosis of non-Hodgkin´s Lymphoma

Vascular endothelial growth factor & basic fibroblast growth factor polymorphism as prognostic factors in Non-Hodgkin Lymphoma

Interleukin –1 Receptor Antagonist Gene Polymorphism and Malignant lymphomas

Risk Prediction Genetic Study of Non-HLA Gene NOD2 Three Polymorphisms in Acute Graft versus Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients

Relationship between C-MYC, BCL-2 and BCL-6 Genetic Abnormalities and Bone Marrow Biopsy in B-Non-Hodgkin Lymphoma

Association between Cytochrome P450 Genetic Polymorphism and Hematological Toxicity of Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP Protocol

Clinicopathological Significance of A20 Genetic Mutation in Diffuse Large B-Cell Lymphoma

Serum miR-26a-5p and miR-199b-5p as a biomarker to predict therapy for Diffuse Large B-cell lymphoma with Hepatitis C Infection

Evaluation of t(14;18)(q32;q21) and BCL2 protein and their prognostic role in follicular lymphoma